Indian markets retreated on Friday, ending a two-day positive streak, with the Sensex falling 720.60 points (0.90%) to 79,223.11 and the NIFTY declining 183.90 points (0.76%) to 24,004.75.

Shriram Properties: Realty firm Shriram Properties announced the strategic sale of a 3.9-acre land parcel in Chennai to a ...

On Tuesday, 2325 stocks advanced, 1648 declined and 106 remained unchanged, with an advance decline ratio of 1.41x on the ...

Huminsulin is used for adult and pediatric patient with Type 1 and Type 2 diabetes mellitus that aids in regulation of blood ...

Driven by higher sales, pharmaceutical giant Lupin Ltd. reported a strong 74.1 per cent year-over-year increase in its ...

Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.

Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to ...

There is a significant Indian population affected with diabetes for both Type 1 and Type 2 Diabetes Mellitus, where Insulin ...

Shares of the pharma stock rose around 2.5 per cent on Tuesday. Lupin share price has a 52-week range of Rs 2,369.90 and Rs 1 ...

The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

The Nifty Index opened negative and after the initial swings in the first half of the session, it further slipped and touched ...